ST. LOUIS, April 12, 2018 /PRNewswire/ -- Guided by the principles of simplification, choice, and competition, Express Scripts (NASDAQ: ESRX) today announced the launch of a new, innovative 12-month ...
Inclusion of neffy on Express Scripts commercial formularies was effective November 22, 2024 and expands access to patients and caregivers managing Type 1 Allergic Reactions SAN DIEGO, Dec. 19, 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results